glucagon like peptide 1 glp 1 receptor agonist medications Glucagon-like peptide-1 receptor: mechanisms and advances in therapy “Weighing In” on GLP-1 Receptor

Novo Nordisk, a pharmaceutical company based in Denmark, made the first of the recent blockbuster drugs, Ozempic, which emerged on the scene as a drug for people with diabetes

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone that helps regulate appetite, digestion, and insulin release, promoting a sense of fullness after meals

These drugs seem to work on the brain's reward system, like they do for food cravings

In one molecule, theyd found a way to address two of the biggest challenges in metabolic health: high blood sugar and excess weight

Baseline and follow-up laboratory monitoring (A1C, renal function, lipid panel) is advisable